Nokia Lumia Prototype SPOTTED and 4 Heavily Traded Shares Turning Heads Today
Sirius XM Radio Inc (NASDAQ:SIRI): Due to strong auto sales, which have helped to increase totals, Sirius XM Radio (NASDAQ:SIRI), has added 622,042. The churn rate of 1.9% has remained unchanged from a year ago and free cash flow of $230 million was recorded at the end of the period. Sirius anticipates a net subscriber growth of 1.6 million with a revenue increase close to $3.4 billion for the fiscal year 2012. Shares are +3.0% pre-market.
Bank of America Corp (NYSE:BAC): Among the ten main groups, in the Standard and Poors 500, energy, industrial and financial shares led in gains today, while J.P Morgan Chase & Co., Bank of America Corp. and Cisco Systems Inc. rose more than 2.6 percent for the largest gain in the Dow Jones Industrial Average.
Nokia Corporation (NYSE:NOK): A Chinese website has posted pictures of, what appears to be, a yellow Lumia phone with an oversized display. At a September 5th, Nokia Corporation world event, there is expectation that the company will unveil WP8 hardware, possibly including a PureView phone.
Chimera Investment Corporation (NYSE:CIM): Though a new auditor was hired this year, Chimera Investment Corporation, (CIM +11%), has still not filed their third quarter, 2011, financial statements. Quarterly and annual reports from the third quarter 2008 through 2011, “can no longer be relied upon,” and will be restated. This restatement, is not expected to affect previously reported income, book values, or dividends.
Pfizer Inc. (NYSE:PFE): Pfizer Inc., has confirmed that they have resolved a U.S. Department of Justice, and Securities and Exchange Commission matter, relating to certain improper payments, in the operations, of two of their subsidiaries, outside of the United States, which Pfizer voluntarily reported to the U.S. government at the beginning of 2004. To resolve those historical issues, a Pfizer indirect subsidiary will enter into a deferred prosecution agreement with the Department of Justice, and pay a fine of $15 million. Under the terms of a civil settlement, with the SEC, Pfizer agreed to a disgorgement of profits of $16 million and a pre-judgment interest of $10.3 million. The DOJ has decided not to bring a criminal action against Pfizer. In a separate civil settlement with the SEC, Pfizer’s Wyeth subsidiary has agreed to a disgorgement of profits of $17.2 million and a pre-judgment interest of $1.66 million. This will resolve issues involving improper operations payments of four subsidiaries that are located outside of the United States. The DOJ and the SEC have made no allegation that anyone at Pfizer’s or Wyeth’s corporate headquarters knew about, or approved of any inappropriate conduct in the matter.
Don’t Miss: Apple Has A New NIGGLE In China.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.